Annual Report

Overview

The report presents 2025 as Bio-heart’s first commercialization year, with the Iberis RDN system approved in China and market access achieved across 21 countries or regions. It describes Board-led ESG oversight supported by an ESG Working Group and reports performance for the Group’s China operations, including 445.45 tonnes of CO2e emissions. The report also details workforce, resource consumption, climate-risk analysis and materiality assessment activities.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2025
Period: 1 January 2025 – 31 December 2025
Language: English
Pages
File size

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services